Hypertension, Vol 21, 322-328, Copyright © 1993 by American Heart Association
KF Hilgers, R Veelken, G Rupprecht, PW Reeh, FC Luft and JF Mann
We developed a novel method to stimulate the sympathetic innervation of the
isolated, perfused rat hind limb to investigate whether a subpressor
concentration of angiotensin II (Ang II) facilitates noradrenergic
transmission in the vascular bed to skeletal muscle. We electrically
stimulated the lumbar sympathetic trunk while perfusing the preparation
with artificial medium. Seventy-five percent of the resulting
frequency-dependent increases in perfusion pressure were mediated by alpha
1-adrenergic receptors. Ang II (10 nM) significantly enhanced the effects
of nerve stimulation at 1 and 10 Hz (by 42% and 35%, respectively). At a
supramaximal stimulation frequency (20 Hz), Ang II prolonged the duration
of the response without changing the peak increase in pressure. The
reuptake inhibitor cocaine did not influence the effects of Ang II at 1 and
10 Hz but blocked the effect at 20 Hz. To control for nonspecific synergism
with norepinephrine, we compared Ang II with vasopressin. Both peptides
potentiated the pressor response to exogenous norepinephrine; however,
vasopressin did not change the pressor response to nerve stimulation at any
frequency. We conclude that Ang II, but not vasopressin, facilitates
noradrenergic transmission in skeletal muscle resistance vessels,
independent of its direct vasoconstrictor activity. The neurovascular
preparation we describe may be useful in addressing other hypotheses
concerning sympathetic transmission in skeletal muscle resistance vessels.
ARTICLES
Angiotensin II facilitates sympathetic transmission in rat hind limb circulation
Department of Medicine-Nephrology, University of Erlangen-Nurnberg, FRG.
This article has been cited by other articles:
![]() |
Y. Uresin, B. Erbas, M. Ozek, E. Ozkok, and A. O. Gurol Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress Journal of Renin-Angiotensin-Aldosterone System, June 1, 2004; 5(2): 93 - 96. [Abstract] [PDF] |
||||
![]() |
S. D. McCole, M. D. Brown, G. E. Moore, R. E. Ferrell, K. R. Wilund, A. Huberty, L. W. Douglass, and J. M. Hagberg Angiotensinogen M235T polymorphism associates with exercise hemodynamics in postmenopausal women Physiol Genomics, August 14, 2002; 10(2): 63 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Abraham Pharmacologic Management of Chronic Heart Failure: A Review Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 168 - 190. [Abstract] [PDF] |
||||
![]() |
P. Medina, A. Acuna, J. B. Martinez-Leon, E. Otero, J. M. Vila, M. Aldasoro, and S. Lluch Arginine Vasopressin Enhances Sympathetic Constriction Through the V1 Vasopressin Receptor in Human Saphenous Vein Circulation, March 10, 1998; 97(9): 865 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Gillies, M. Lu, H. Wang, and R. M. K. W. Lee AT1 Receptor Antagonist Treatment Caused Persistent Arterial Functional Changes in Young Spontaneously Hypertensive Rats Hypertension, December 1, 1997; 30(6): 1471 - 1478. [Abstract] [Full Text] |
||||
![]() |
H. Murakami, J.-L. Liu, and I. H. Zucker Angiotensin II Enhances Baroreflex Control of Sympathetic Outflow in Heart Failure Hypertension, February 1, 1997; 29(2): 564 - 569. [Abstract] [Full Text] |
||||
![]() |
A. Ichihara, E. W. Inscho, J. D. Imig, R. E. Michel, and L. G. Navar Role of Renal Nerves in Afferent Arteriolar Reactivity in Angiotensin-Induced Hypertension Hypertension, January 1, 1997; 29(1): 442 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Veelken, K. F. Hilgers, A. Stetter, H.-G. Siebert, R. E. Schmieder, and J. F.E. Mann Nerve-Mediated Antidiuresis and Antinatriuresis After Air-Jet Stress Is Modulated by Angiotensin II Hypertension, November 1, 1996; 28(5): 825 - 832. [Abstract] [Full Text] |
||||
![]() |
L. C. Rump, C. Bohmann, U. Schaible, W. Schultze-Seemann, and P. J. Schollmeyer ß-Adrenergic, Angiotensin II, and Bradykinin Receptors Enhance Neurotransmission in Human Kidney Hypertension, September 1, 1995; 26(3): 445 - 451. [Abstract] [Full Text] |
||||
![]() |
D. N. Muller, K. F. Hilgers, J. Bohlender, A. Lippoldt, J. Wagner, W. Fischli, D. Ganten, J. F. E. Mann, and F. C. Luft Effects of Human Renin in the Vasculature of Rats Transgenic for Human Angiotensinogen Hypertension, August 1, 1995; 26(2): 272 - 278. [Abstract] [Full Text] |
||||
![]() |
S. Taddei, A. Virdis, P. Mattei, S. Favilla, and A. Salvetti Angiotensin II and Sympathetic Activity in Sodium-Restricted Essential Hypertension Hypertension, April 1, 1995; 25(4): 595 - 601. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |